McKesson considers selling IT unit

A sale or merger may be in the cards for McKesson’s IT unit as the company faces pricing pressure from its main drug-distribution business, reports The Wall Street Journal, citing “people familiar with the matter.”

Advertisement

McKesson’s IT unit reported $2.9 billion in sales and a $519 million operating profit for the fiscal year that ended in March. However, McKesson reported $188 billion in sales and a $3.6 billion operating profit in its drug-distribution business for that same time period.

According to WSJ, companies are increasingly narrowing their business focuses on their core units, especially when profit margins on ancillary businesses differ so drastically.

McKesson is just considering options right now, according to the sources.

More articles on McKesson:

4 recent vendor contracts, go-lives 
Joliet Radiological contracts with McKesson for RCM services 
McKesson, ZeOmega integrate preauthorization software 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.